Download pdf
Trends in the Future of China's Retail Pharmacy Industry
- 1 University College London
* Author to whom correspondence should be addressed.
Abstract
Retail pharmacies are the largest market for the sale of medicines in China. In recent years, outbound mergers and acquisitions have become an essential means of promoting the growth of the pharmaceutical industry, considering the industry's increasing concentration and degree of the chain. Furthermore, the background of the rise of domestic e-commerce combined with the stimulus of the covid-19 pandemic has ushered in a golden period for online pharmacy development. In addition, from the perspective of the policy environment, the prescription outflow trend will also drive the development of the pharmacy industry. In the future, the competition between online and physical pharmacies will become more intense. Chinese leading pharmaceutical companies have all made strategic moves to respond to changes in the industry. By introducing an example of a leading domestic company acquiring a small pharmacy, this paper aims to provide insight to investors into the strategic thinking of pharmacies in the context of the current industry development in China.
Keywords
pharmaceutical industry, retail pharmacy, China
[1]. China Retail Pharmacy Market Analysis (2022). https://mp.weixin.qq.com/s?__biz=MjM5NjQ2ODMwMA==&mid=2651110811&idx=2&sn=04dfe3b89a555bfcb280e36feb41cc20&chksm=bd18deb88a6f57ae1bc79adf318372fd810bfee82b1f484783198c47edfb90d19e275bb4a0f4&scene=27
[2]. Yang, Y.; Geng, X.; Liu, X.; Wen, X.; Wu, R.; Cui, D.; Mao, Z. (2022). Antibiotic Use in China’s Public Healthcare Institutions during the COVID-19 Pandemic: An Analysis of Nationwide Procurement Data, 2018–2020. Front. Pharmacol. 2022, 13, 813213.
[3]. Sinolink Securities. (2022). Equity Research Reports of Alibaba Health Information Technology Limited. pp.4. https://www.hanghangcha.com/pdf.html
[4]. Liu, J.; Su, J. (2013). Research on Motivation of China M&A Tide: Based on the Comparison of the Western Theories with Chinese Enterprises. School of Management, Dalian University of Technology. 2013,16(02):57-63.
[5]. National Healthcare Security Administration. (2021). Guidance from the National Health Care Commission on establishing and improving the "dual channel" management mechanism for drugs negotiated by the National Health Insurance. https://www.gov.cn/zhengce/zhengceku/2021-05/10/content_5605595.htm
[6]. Jiang,G.(2021).How Did Merger and Acquisitions Boost the Market Power-Evidence from Chinses Firms. School of Economics of Xiamen University, Xiamen.2021(05):170-188. http://epub1.yyttgd.top/kns8/defaultresult/index
[7]. Ministry of Commerce of The People’s of Republic of China. (2022). Statistical Report on Pharmaceutical Circulation Industry.pp.2,31. http://scyxs.mofcom.gov.cn/article/c/202209/20220903345957.shtml
[8]. Xie, T. (2022). Research on the Motivation and Performance of the Continuous Mergers and Acquisitions of LBX
[9]. Yu,M. (2021). Study on the Performance of continuous mergers and acquisitions of large pharmacies under the background of prescription Outflow. http://epub1.yyttgd.top/kns8/defaultresult/index
[10]. JRJ News. (2021). LBX Pharmacy to Acquire Hua Tuo Pharmacy, Receives Question Letter from SSE for High Premium, High Goodwill, Performance Betting. https://baijiahao.baidu.com/s?id=1709131671929178919&wfr=spider&for=pc
[11]. Historical share price of LBX pharmacy (2021). https://data.eastmoney.com/stockcalendar/603883.html
[12]. Shanghai Stock Exchange. (2021). In relation to the acquisition of 51% equity interest in Hebei Hua Tuo Pharmacy by LBX Pharmacy Chain Joint Stock Company on the Acquisition of 51% Equity Interest in Hebei Hua Tuo Pharmacy. http://www.sse.com.cn/disclosure/credibility/supervision/inquiries/enquiry/c/8143126234629003.pdf.
[13]. Sohu News. (2018). Back-to-back announcements from Yifeng, significant progress in the acquisition of Xinxing. https://www.sohu.com/a/256403466_377305
[14]. Announcement on the Progress of the Acquisition of 71.9643% Equity Interest in Hunan Huiren Great Health Industry Development Company Limited by LBX Pharmacy (2022). https://data.eastmoney.com/notices/detail/603883/AN202204211560656539.html
Cite this article
Hu,Y. (2023). Trends in the Future of China's Retail Pharmacy Industry. Advances in Economics, Management and Political Sciences,41,152-158.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 7th International Conference on Economic Management and Green Development
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).